FY2027 ICD-10-CM reference
E22: Hyperfunction of pituitary gland
By the HCC Buddy Coding Team
The official ICD-10-CM descriptor is Hyperfunction of pituitary gland. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.
Nonbillable heading. Verified against the official FY2027 order file.
Oct to Dec 2026, PY2027
CMS-HCC V28
Not applicableCMS-HCC V24
Not applicableESRD
Not applicableRxHCC
Not applicablePACE (CMS-HCC V22 component)
Not applicablePACE ESRD (ESRD V21 component)
Not applicablePACE RxHCC (2018/2019 component)
Not applicableJan to Sep 2027, PY2028
CMS-HCC V28
Not applicableCMS-HCC V24
Not applicableESRD
Not applicableRxHCC
Not applicablePACE (CMS-HCC V22 component)
Not applicablePACE ESRD (ESRD V21 component)
Not applicablePACE RxHCC component
Not applicableOct to Dec 2026, BY2026
HHS-HCC
Not applicableJan to Sep 2027, BY2027
HHS-HCC
Not applicableMore specific FY2027 codes
- E22.0: Acromegaly and pituitary gigantismBillable code
- E22.1: HyperprolactinemiaBillable code
- E22.2: Syndrome of inappropriate secretion of antidiuretic hormoneBillable code
- E22.8: Other hyperfunction of pituitary glandBillable code
- E22.9: Hyperfunction of pituitary gland, unspecifiedBillable code
FY2027 Tabular instructions
Instructions below include applicable chapter, section and parent-code notes. Each note identifies where it appears in the official source.
Instructional note
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Source: E00-E89 (chapter, inherited).
Excludes1
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Source: E00-E89 (chapter, inherited).
Excludes1
galactorrhea (N64.3)
Source: E20-E35 (section, inherited).
Excludes1
gynecomastia (N62)
Source: E20-E35 (section, inherited).
Excludes1
Cushing's syndrome (E24.-)
Source: E22 (category, direct).
Excludes1
Nelson's syndrome (E24.1)
Source: E22 (category, direct).
Excludes1
overproduction of ACTH not associated with Cushing's disease (E27.0)
Source: E22 (category, direct).
Excludes1
overproduction of pituitary ACTH (E24.0)
Source: E22 (category, direct).
Excludes1
overproduction of thyroid-stimulating hormone (E05.8-)
Source: E22 (category, direct).
Compare the FY2027 additions, removals and billable-status changes
What does E22 mean in FY2027?
The official ICD-10-CM descriptor is Hyperfunction of pituitary gland. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.
Is E22 billable in FY2027?
The FY2027 order file marks E22 as a nonbillable heading. Select a complete billable child code.
Does E22 map to an HCC?
Risk-model mapping is not applicable to this nonbillable heading. Check a complete billable child code.
Source: CMS FY2027 ICD-10-CM order file. Payment model: CMS CY 2027 Rate Announcement. Read the FY2027 Official Guidelines.
Review the FY2026 April edition
